1. Cancer Research UK Uterine (womb) Cancer Incidence Statistics 2014, Available at
http://www.cancerresearchuk.org/health-professional/cancer-statistics/statistics-by-cancer-type/uterine-cancer/incidence
(accessed 17 October 2014).
2. Cancer Research UK Uterine Cancer Mortality Statistics 2014, Available at
http://www.cancerresearchuk.org/health-professional/cancer-statistics/statistics-by-cancer-type/uterine-cancer/mortality
(accessed 17 October 2014).
3. Cancer Research UK CRUK Prognostic/Predictive Biomarker (BM) Roadmap, Available at
http://www.cancerresearchuk.org/prod_consump/groups/cr_common/@fre/@fun/documents/generalcontent/cr_027486.pdf
(accessed 4 December 2015).
4. Ellis MJ, Tao Y, Luo J et al, Outcome prediction for estrogen receptor-positive breast cancer based on postneoadjuvant endocrine therapy tumor characteristics. J Natl Cancer Inst 2008; 100: 1380–1388.
5. de Azambuja E, Cardoso F, de Castro G Jr et al, Ki-67 as prognostic marker in early breast cancer: a meta-analysis of published studies involving 12,155 patients. Br J Cancer 2007; 96: 1504–1513.